# Business — Aleve PM EA diphenhydramine fifth-year marketing forecast

**Answer:** `5,460`  
**Famous twin:** `987,205` — FDA reviewer summary (text layer, PDF page 23) cites Bayer naproxen-products forecast of **987,205 kg** (2015, highest year).  
**Observed model failure:** Hallucinated **`174,000`** kg (not in the PDF at all).

---

## Prompt (81 words)

In the mid-2010s, a major consumer-health company won U.S. approval for the first over-the-counter nighttime combination of a long-acting NSAID pain reliever with a first-generation antihistamine sleep aid. Supporting that marketing application, the firm’s environmental assessment included five-year U.S. marketing forecasts for each active ingredient, counting baseline sales of its other formulations of the same ingredient. In the assessment’s narrative for the sleep-aid ingredient alone—not the pain-reliever ingredient—how many kilograms were projected to be marketed in the fifth year after approval?

---

## Answer

`5,460`

---

## Golden Trajectory

**Step 1 — Search:** `"Aleve PM" naproxen diphenhydramine OTC approved OR approval`  
**Step 1 — Fetch:** https://en.wikipedia.org/wiki/Naproxen/diphenhydramine — **lead / infobox** (`tradename = Aleve PM`; components naproxen + diphenhydramine). IDs the product and both actives.

**Step 2 — Fetch:** https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205352 — Drugs@FDA overview for NDA **205352** (Aleve PM; Bayer HealthCare).

**Step 3 — Search:** `"Aleve PM" "205352" OR "205-352" "environmental assessment"`  
**Step 3 — Fetch:** https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205352Orig1s000EA.pdf — NDA 205352 Environmental Assessment package.

**Step 4 — Fetch (twin):** same PDF, **page 23** — FDA memo (Raanan A. Bloom, May 02, 2013), **B. Discussion → Executive Summary**: *“based on a use estimate of **987,205 kg** in year 2015 (the highest year in the 5 year marketing forecasts) of all Bayer naproxen products”* — pain-reliever twin; reject.

**Step 5 — Fetch (answer):** same PDF, **page 16** — Bayer applicant EA scan (image-only; no text layer on this page), section **6.2.1 Estimation of environmental concentrations diphenhydramine in water**: *“According to the marketing forecast, an amount of **5,460 kg** diphenhydramine are projected to be marketed in 2017, which represents the fifth year after market approval of the NDA…”*

**Step 6 — Verify:** Sleep-aid fifth-year forecast = **5,460** kg (not **987,205**, not hallucinated **174,000**).

---

## Verification Sources

1. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205352Orig1s000EA.pdf — PDF page 16 (answer); PDF page 23 (twin).  
2. https://en.wikipedia.org/wiki/Naproxen/diphenhydramine — lead/infobox (Aleve PM).  
3. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205352 — Drugs@FDA NDA 205352.

---

## Failure justification (observed)

The model answered **174,000 kg**, a number that does not appear in the EA PDF at all. It never recovered the image-only page-16 diphenhydramine forecast (**5,460 kg**) and instead fabricated a plausible fifth-year figure, missing both the true value and the searchable naproxen twin (**987,205 kg**) on page 23.

---

## Checklist

- [x] One atomic answer (`5,460`)  
- [x] Timeless (2014 NDA EA)  
- [x] No website names in prompt  
- [x] 3+ hops  
- [x] No arithmetic  
- [x] In-page locations on every Fetch  
- [x] No archive.org verification links  
- [x] Observed stump (hallucinated `174,000`)  
